News

FFAR Funds Veterinary Research to Address Pandemic Diseases

In response to the coronavirus pandemic, the Foundation for Food and Agriculture Research (FFAR) is funding five additional Vet Fellowships to conduct pandemic and zoonotic research. The FFAR Vet Fellows program equips veterinary students with the expertise to address future agricultural challenges.

Up to 75 percent of emerging infectious diseases are zoonotic, meaning a pathogen can spread from animals to humans. Both coronaviruses and influenza viruses can be zoonotic and can be found in agricultural animals such as poultry and pigs. Research on food-animal production and veterinary medicine can reduce the threat of zoonotic pathogens. Yet, veterinary students have limited opportunities to research zoonotic diseases in agriculture.

“The coronavirus is an example of how pathogens can move between humans and animals,” said FFAR’s Executive Director Sally Rockey. “Understanding new diseases in animals, and especially how they spread, is vital to slowing transmission and developing remedies. FFAR is expanding the Vet Fellows to assure we have the expertise in the veterinary community to address what could be future pandemics.”

A recent JAVMA article agrees that veterinarians are needed in the research field to be part of the solution. FFAR is ensuring that the future scientific workforce includes veterinarians with expertise in zoonotic pathogens by funding five additional Vet Fellowships to conduct research on pathogens that threaten agricultural productivity and human health. To bolster the scientific workforce in response to the coronavirus, FFAR is not requiring the 2020 Vet Fellows to secure matching funds. Additionally, FFAR and the Association of American Veterinary Medical Colleges (AAVMC), who partners with FFAR to administer the program, extended the nomination deadline to May 6, 2020.

The FFAR Vet Fellows program will still support ten students to conduct research on agricultural productivity, public health and environmental sustainability. Information about applying for the FFAR Vet Fellows Program is available on FFAR’s website. The fifteen 2020 FFAR Vet Fellows will be announced in summer 2020.

Recent News

06/29/2022

Bio-plastics startup wins Lighthouse Labs pitch contest

Charlottsville, VA (Virginia Business) – While pitching to the sharks, entrepreneur Alec Brewer told them, “I do have white powder in my pocket,” before quickly clarifying that it wasn’t an illicit substance: “It’s PHB! It’s PHB!” The co-founder and CEO of Charlottesville-based biodegradable plastics manufacturer Ourobio, Brewer explained that his company makes PHB, or polyhydroxybutyrate,

06/26/2022

USA FDA Grants Fast Track Designation to ReAlta Life Sciences’ Lead Compound RLS-0071

ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE). RLS-0071 is the Company’s lead dual

06/20/2022

Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

New patent covers the use of the full genetic panel measuring all five genetic biomarkers CHARLOTTESVILLE, Va., — Adial Pharmaceuticals, Inc. (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,351,154 was issued on June 7, 2022, by